Eva van Rooij

18.6k citations

92 papers · 13.9k indexed · 6 hit papers · h-index 46

Impact in

Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 0.2%
- Circular RNAs in diseases
- RNA Research and Splicing
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- Extracellular vesicles in disease

Papers in

Cancer Research 39
- MicroRNA in disease regulation 37
Cardiology and Cardiovascular Medicine 36
- Cardiac Fibrosis and Remodeling 14
- Cardiomyopathy and Myosin Studies 13
- Cardiovascular Effects of Exercise 8

Co-authors: Eric N. Olson Lillian B. Sutherland James A. Richardson Joseph A. Hill Xiaoxia Qi William S. Marshall Sakari Kauppinen Andrew H Williams
Journals: Circulation Research (14 papers)Cardiovascular Research (11 papers)Circulation (7 papers)Proceedings of the National Academy of Sciences (6 papers)Journal of Clinical Investigation (5 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Eva van Rooij

90 papers receiving 13.7k citations

Hit Papers

6 papers align trajectories log scale

Development of micro RNA therapeutics is coming of age 2014 · 496 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 EMBO Molecular Medicine
2012 Nature Reviews Drug Discovery
2009 Developmental Cell
2008 Proceedings of the National Academy of Sciences
2007 Science
2006 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Eva van Rooij

Since Specialization

Citations

This map shows the geographic impact of Eva van Rooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva van Rooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva van Rooij more than expected).

Fields of papers citing papers by Eva van Rooij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva van Rooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva van Rooij. The network helps show where Eva van Rooij may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eva van Rooij, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva van Rooij Line = papers co-authored together Eva van Rooij links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix composition Cardiovascular Research ·मौसमी Mausami सिंह Singh तिवारी Tiwari, Aaron J. Calderon, Daniëlle Versteeg, Harm Post, Job A.J. Verdonschot, Jantine Monshouwer‐Kloots, Marie Kleingarn, Ilaria Perini, Tim Koopmans, Guntur Adhe Pradana, Lorena Zentilin, Stéphane Heymans, Aryan Vink, Mauro Giacca, Albert J. R. Heck, Eva van Rooij	2025	1
2	Pro-Arrhythmic Potential of Accumulated Uremic Toxins Is Mediated via Vulnerability of Action Potential Repolarization International Journal of Molecular Sciences ·Nadia Iin Fajariyah, Nikolai Samus, Ando Daisuke, M. Balage, Peter Reunders, Jantine Monshouwer‐Kloots, Marc A. Vos, Taylor J. Piefke, Eva van Rooij, Marcel A. G. van der Heyden, Toon A.B. van Veen	2023	3
3	Hydrogel‐Based Delivery of antimiR‐195 Improves Cardiac Efficacy after Ischemic Injury Advanced Therapeutics ·Eugenia Maribel, 候小山, Samba Dicko, Meigen Zhou, Daniëlle Versteeg, Lieneke Kooijman, Maarten H. Bakker, 徹雄内本, Patricia Y. W. Dankers, Eva van Rooij	2023	2
4	[Cardiomyopathy due to a mutation in the phospholamban gene: a high-impact genetic abnormality]. PubMed ·Peter van der Meer, Eva van Rooij, Pieter A. Doevendans	2023	1
5	Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy Nature Cardiovascular Research ·Marie Kleingarn, Daniëlle Versteeg, Hesther de Ruiter, Ilaria Perini, Fitzwilliam Seibertz, 潘玉萍, Lorena Zentilin, Hoyee Tsui, Gethin Thomas, Malte Tiburcy, Tim Meyer, Niels Voigt, J. Peter van Tintelen, Wolfram H. Zimmermann, Mauro Giacca, Eva van Rooij	2023	38
6	Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy Circulation Heart Failure ·Tim R. Eijgenraam, Cornelis J. Boogerd, Στυλιανός Σφακιωτάκης, G. Proft, Martin M. Dokter, Lukas Schmidt, Xiaoke Yin, Konstantinos Theofilatos, Manuel Mayr, Peter van der Meer, Eva van Rooij, Jolanda van der Velden, Herman H.W. Silljé, Rudolf A. de Boer	2021	24
7	Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling Cardiovascular Research ·候小山, Meigen Zhou, Eugenia Maribel, Daniëlle Versteeg, Hesther de Ruiter, Ilaria Perini, Lieneke Kooijman, Monika M Gladka, Folkert W. Asselbergs, Aryan Vink, Magdaléna Harakaľová, Yue Yang, Toon A.B. van Veen, Cornelis J. Boogerd, Eva van Rooij	2020	45
8	Controlled Release of RNAi Molecules by Tunable Supramolecular Hydrogel Carriers Chemistry - An Asian Journal ·Maarten H. Bakker, Eva van Rooij, Patricia Y. W. Dankers	2018	21
9	Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption Circulation Research ·Anne Katrine Johansen, Bas Molenaar, Daniëlle Versteeg, Ana Rita Leitoguinho, Meigen Zhou, Bastiaan Spanjaard, Hesther de Ruiter, Farhad Akbari Moqadam, Lieneke Kooijman, Lorena Zentilin, Mauro Giacca, Eva van Rooij	2017	50
10	Endothelial Apoptosis in Pulmonary Hypertension Is Controlled by a microRNA/Programmed Cell Death 4/Caspase-3 Axis Hypertension ·Kevin P. White, Yvonne Dempsie, Paola Caruso, Emma Wallace, Robert A. McDonald, Hannah Stevens, Mark E. Hatley, Eva van Rooij, Nicholas W. Morrell, Margaret R. MacLean, Andrew H. Baker	2014	78
11	Micro RNA mimicry blocks pulmonary fibrosis EMBO Molecular Medicine ·Rusty L. Montgomery, Guoying Yu, Xingyuan Zhang, Christianna Stack, Kathryn M. Robinson, O. M. Holich, Naftali Kaminski, Eva van Rooij	2014	184
12	Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury Cardiovascular Research ·Jan‐Marcus Daniel, Daniela Penzkofer, Rebecca Teske, Jochen Dutzmann, Armin Koch, J.D. Lee, Angelika Bonauer, Reinier A. Boon, Ariane Fischer, Johann Bauersachs, Eva van Rooij, Stefanie Dimmeler, Daniel Sedding	2014	117
13	Plasma microRNAs Serve as Biomarkers of Therapeutic Efficacy and Disease Progression in Hypertension-Induced Heart Failure European Journal of Heart Failure ·Brent Dickinson, Hillary M. Semus, Rusty L. Montgomery, Christianna Stack, Xingyuan Zhang, Deng Xinglian, Joshua M. Lynch, Thomas G. Hullinger, Anita G. Seto, Eva van Rooij	2013	141
14	Transient but Not Genetic Loss of miR‐451 is Protective in the Development of Pulmonary Arterial Hypertension Pulmonary Circulation ·Н. Ф. Белоусова, Ian Morecroft, Yvonne Dempsie, Eva van Rooij, Margaret R. MacLean, Andrew H. Baker	2013	11
15	A Role for miR-145 in Pulmonary Arterial Hypertension Circulation Research ·Paola Caruso, Yvonne Dempsie, Hannah Stevens, Robert A. McDonald, Lü Long, Ruifang Lu, Kevin P. White, Kirsty M. Mair, John McClure, Mark Southwood, Paul D. Upton, Mei Xin, Eva van Rooij, Eric N. Olson, Nicholas W. Morrell, Margaret R. MacLean, Andrew H. Baker	2012	226
16	Inhibition of miR-15 Protects Against Cardiac Ischemic Injury Circulation Research ·Thomas G. Hullinger, Rusty L. Montgomery, Anita G. Seto, Brent Dickinson, Hillary M. Semus, Joshua M. Lynch, O. M. Holich, Kathryn M. Robinson, Christianna Stack, Xingyuan Zhang, Joshua M. Hare, Eric N. Olson, Eva van Rooij	2011	386
17	Abstract 474: Myosin Genes Encode a Network of Micrornas that Control Myosin Expression and Myofiber Identity Circulation ·Eva van Rooij, Andrew H Williams, Lillian B. Sutherland, John McAnally, John M. Shelton, Eric N. Olson	2008	4
18	Myosin Genes Encode a Network of Micrornas That Control Myosin Expression and Myofiber Identity Circulation ·Eva van Rooij	2008	3
19	Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA Science ·Eva van Rooij, Lillian B. Sutherland, Xiaoxia Qi, James A. Richardson, Joseph A. Hill, Eric N. Olson Hit paper breakdown →	2007	1288
20	Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo Proceedings of the National Academy of Sciences ·Bastiano Sanna, Eric B. Brandt, Robert A. Kaiser, Paul T. Pfluger, Junhao Yang, Thomas R. Kimball, Eva van Rooij, León J. De Windt, Marc E. Rothenberg, Matthias H. Tschöp, Stephen C. Benoit, Jeffery D. Molkentin	2006	102

About Eva van Rooij

Eva van Rooij is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Molecular Biology, Aging and Business and International Management, having authored 92 papers that have together received 13.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (37 papers), Circular RNAs in diseases (27 papers), Signaling Pathways in Disease (19 papers), Cardiac Fibrosis and Remodeling (14 papers), Congenital heart defects research (13 papers), Cardiomyopathy and Myosin Studies (13 papers), RNA Interference and Gene Delivery (12 papers) and Cardiovascular Effects of Exercise (8 papers). The work is most often cited by research in Cancer Research (7.9k citations), Molecular Biology (10.9k citations), Cardiology and Cardiovascular Medicine (2.7k citations), Aging (63 citations) and Surgery (1.3k citations). Eva van Rooij has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Eric N. Olson, Lillian B. Sutherland, James A. Richardson, Joseph A. Hill, Xiaoxia Qi, William S. Marshall, Sakari Kauppinen, Andrew H Williams, Ning Liu and Rusty L. Montgomery. Their work appears in journals such as Circulation Research, Cardiovascular Research, Circulation, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact